[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620081":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":59,"collaborators":24,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":24,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":24,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":24,"overallStatus":38,"whyStopped":24,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Kafrelsheikh University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Study group (group A)","EXPERIMENTAL","Patients will receive the transcutaneous tibial nerve stimulation (TTNS) and traditional treatment (Nonsteroidal anti-inflammatory drugs) for three sessions a week for four consecutive weeks.",[13],"Other: Transcutaneous tibial nerve stimulation (TTNS)",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group (group B)","ACTIVE_COMPARATOR","Patients will receive the placebo transcutaneous tibial nerve stimulation (TTNS) and traditional treatment (Nonsteroidal anti-inflammatory drugs) for three sessions a week for four consecutive weeks.",[19],"Drug: Traditional treatment (Nonsteroidal anti-inflammatory drugs)",[21,25],{"type":6,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"Transcutaneous tibial nerve stimulation (TTNS)",[9],null,{"type":26,"name":27,"description":17,"armGroupLabels":28,"otherNames":24},"DRUG","Traditional treatment (Nonsteroidal anti-inflammatory drugs)",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},"Amira R Darwish, MBBCH","CONTACT","00201062565206","amirarashad13@gmail.com",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Kafrelsheikh University (Faculty of Physical Therapy)","RECRUITING","Kafr ash Shaykh","Kafrelsheikh","33516","Egypt","EG",{"type":45,"coordinates":46},"Point",[47,48],30.93991,31.11174,{"lat":48,"lon":47},[51,52,55,57],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},{"name":53,"role":54,"phone":24,"phoneExt":24,"email":24},"Fayiz F Elshamy, MD","SUB_INVESTIGATOR",{"name":56,"role":54,"phone":24,"phoneExt":24,"email":24},"Muhammad F AbdulGalil, MD",{"name":58,"role":54,"phone":24,"phoneExt":24,"email":24},"Mostafa F Ellakany, MD",{"type":60,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Amira Rashad Mohamed Darwish","B.Sc. in Physical Therapy, Pharos University in Alexandria","100620081","transcutaneous-tibial-nerve-stimulation-on-women-with-primary-dysmenorrhea-100620081",false,"NCT07352982","Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea","Effect of Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea","Inclusion Criteria:\n\n* Age ranges from 20-25 years old.\n* Body mass index (BMI) doesn't exceed 30 kg\u002Fm2.\n* Patients referred from a Gynecologist with a diagnosis of Primary Dysmenorrhea (PD).\n* Patients have regular menstrual cycles.\n* Patients suffer from pain located in the suprapubic area, abdomen, lower lumbar area, perineum, and\u002For medial aspect of the thighs during at least half of their annual menstrual cycles and\u002For in the last 3 cycles.\n\nExclusion Criteria:\n\n* Patients diagnosed with gynecological pathology.\n* Patients taking oral contraceptives or had an intrauterine device implanted.\n* Patients had bad obstetric situations or diseases that could interfere with participation.\n* Patients have certain disorders including uncorrected coagulopathies, severe comorbid disorder, cancer in the last 5 years or at present, presence of erosions on the inner aspect of the ankle, severe mental disorders, or neuropathies affecting the lower limb.\n* Patients who are smoking or taking oral sedatives.\n* Patients had undergone surgery or childbirth in the last 6 months.\n* Patients who are pregnant.","FEMALE","20 Years","25 Years",{"count":74,"type":75},32,"ESTIMATED","INTERVENTIONAL",[78],"NA","This study aims to investigate the effects of transcutaneous tibial nerve stimulation (TTNS) on women with primary dysmenorrhea (PD).",[81,82,83],"Transcutaneous Tibial Nerve Stimulation","Women","Primary Dysmenorrhea","2026-01-19",{"date":86,"type":87},"2026-01-21","ACTUAL",{"date":84,"type":87},{"date":90,"type":75},"2026-07-01",{"name":5,"class":6},1]